Emmes Acquires Orphan Reach
contractpharma
May 13, 2021
Emmes, a global, full-service CRO, has acquired Orphan Reach, a company headquartered in the UK with offices in Ireland, Germany, India, Canada, and the U.S., dedicated to clinical research in rare diseases.